The market expects Merus N.V. (MRUS) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss ...

Core Viewpoint - MGE is anticipated to report a year-over-year increase in earnings driven by higher revenues, with the consensus EPS estimate at $0.98, reflecting a 5.4% increase, and revenues expected to reach $202.42 million, up 5.8% from the previous year [1][3]. Earnings Expectations - The earnings report could positively influence MGE's stock price if actual results exceed expectations, while a miss could lead to a decline [2]. - The consensus EPS estimate has been revised down by 2.5% over the last 30 days, indicating a reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model compares the Most Accurate Estimate to the Zacks Consensus Estimate, with MGE's Most Accurate Estimate aligning with the consensus, resulting in an Earnings ESP of 0% [5][10]. - A positive Earnings ESP is a strong indicator of an earnings beat, especially when combined with a favorable Zacks Rank [8]. Historical Performance - MGE has not surpassed consensus EPS estimates in the last four quarters, with the most recent quarter showing a significant miss of -27.38% [12][13]. Industry Comparison - NRG Energy, another player in the electric power industry, is expected to report earnings of $1.80 per share, a 125% year-over-year increase, with revenues projected at $2.89 billion, down 61% from the previous year [17]. - NRG's consensus EPS estimate has been revised up by 28.8% in the last 30 days, but it also has an Earnings ESP of 0.00%, making predictions about beating the consensus challenging [18].

Sezzle Inc. (SEZL) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock ...

Core Viewpoint - Sigma Lithium Corporation (SGML) is anticipated to report a year-over-year increase in earnings driven by higher revenues for the quarter ended March 2025, with the consensus outlook suggesting a significant impact on the stock price based on actual results compared to estimates [1][2]. Earnings Expectations - The upcoming earnings report is scheduled for May 14, 2025, with expectations that better-than-expected results could lead to a stock price increase, while disappointing results may cause a decline [2]. - The consensus estimate for quarterly earnings is projected at $0.01 per share, reflecting a year-over-year increase of +116.7%, with revenues expected to reach $50.75 million, up 35.7% from the previous year [3]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised down by 126.67%, indicating a reassessment by analysts of their initial estimates [4]. - The Most Accurate Estimate for Sigma Lithium aligns with the Zacks Consensus Estimate, resulting in an Earnings ESP of 0%, suggesting no recent differing analyst views [10][11]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict the likelihood of actual earnings deviating from consensus estimates, with a positive ESP being a strong predictor of an earnings beat, especially when combined with a strong Zacks Rank [6][8]. - Sigma Lithium currently holds a Zacks Rank of 5, which complicates the prediction of an earnings beat [11]. Historical Performance - In the last reported quarter, Sigma Lithium was expected to post earnings of $0.06 per share but instead reported a loss of $0.08, resulting in a surprise of -233.33% [12]. - The company has not achieved an earnings beat in any of the last four quarters [13]. Conclusion - While Sigma Lithium is not positioned as a compelling earnings-beat candidate, investors are advised to consider other factors when making decisions regarding the stock ahead of the earnings release [16].

Nu Holdings Ltd. (NU) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report. On the other hand, if they miss, the stock m ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Avino Silver (ASM) reports results for the quarter ended March 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on May 13, 2025, might help the stock move higher if these key numbers are better than expecta ...

Company Overview - Under Armour (UAA) is expected to report a year-over-year decline in earnings due to lower revenues for the quarter ended March 2025, with a consensus EPS estimate of a loss of $0.09 per share, representing a -181.8% change from the previous year [1][3] - Revenues are anticipated to be $1.16 billion, down 13.1% from the same quarter last year [3] Earnings Expectations - The earnings report is scheduled for release on May 13, 2025, and could influence the stock price significantly depending on whether the actual results exceed or fall short of expectations [2] - The consensus EPS estimate has been revised 33.33% higher in the last 30 days, indicating a more optimistic outlook from analysts [4] Earnings Surprise Prediction - The Zacks Earnings ESP (Expected Surprise Prediction) model shows a positive Earnings ESP of +20.75% for Under Armour, suggesting a likelihood of beating the consensus EPS estimate [10][11] - The company currently holds a Zacks Rank of 2 (Buy), which further supports the expectation of an earnings beat [11] Historical Performance - Under Armour has a strong track record, having beaten consensus EPS estimates in the last four quarters, including a notable surprise of +166.67% in the most recent quarter [12][13] Industry Context - In comparison, Crocs (CROX), another player in the textile-apparel industry, is expected to report earnings of $2.51 per share for the same quarter, reflecting a -16.9% year-over-year change, with revenues projected at $909.58 million, down 3.1% [17] - Crocs has a negative Earnings ESP of -0.32% and a Zacks Rank of 4 (Sell), making it challenging to predict an earnings beat [18]

Core Viewpoint - Gladstone Investment (GAIN) is anticipated to report a year-over-year decline in earnings despite an increase in revenues for the quarter ending March 2025, with the consensus outlook indicating a potential impact on its near-term stock price [1][2]. Earnings Expectations - The upcoming earnings report is expected to reveal quarterly earnings of $0.23 per share, reflecting a year-over-year decrease of 4.2%, while revenues are projected to be $24.78 million, an increase of 4.8% from the previous year [3]. - The consensus EPS estimate has been revised down by 1.43% over the last 30 days, indicating a bearish sentiment among analysts regarding the company's earnings prospects [4][10]. Earnings Surprise Prediction - The Zacks Earnings ESP model shows a negative Earnings ESP of -1.43%, suggesting that the Most Accurate Estimate is lower than the Zacks Consensus Estimate, complicating predictions of an earnings beat [11][10]. - The company currently holds a Zacks Rank of 3 (Hold), which further indicates uncertainty regarding the likelihood of surpassing the consensus EPS estimate [11]. Historical Performance - In the last reported quarter, Gladstone Investment was expected to post earnings of $0.24 per share but delivered only $0.23, resulting in a surprise of -4.17% [12]. - The company has not exceeded consensus EPS estimates in any of the last four quarters, highlighting a trend of underperformance [13]. Industry Comparison - In comparison, Morgan Stanley Direct Lending Fund (MSDL), another player in the Zacks Financial - SBIC & Commercial Industry, is expected to report earnings of $0.56 per share for the same quarter, reflecting a year-over-year decline of 11.1%, with revenues anticipated at $103.52 million, up 4.5% [17]. - Similar to Gladstone Investment, Morgan Stanley Direct Lending Fund has a negative Earnings ESP of -3.57% and a Zacks Rank of 3, making it difficult to predict an earnings beat [18].

The market expects 908 Devices Inc. (MASS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on May 13, 2025, might help the stock move higher if these key numbers ar ...

Company Overview - Ovid Therapeutics (OVID) is expected to report a quarterly loss of $0.14 per share, reflecting a year-over-year change of +17.7% [3] - Revenues are anticipated to be $0.07 million, down 53.3% from the same quarter last year [3] Earnings Expectations - The consensus EPS estimate has remained unchanged over the last 30 days, indicating a stable outlook from covering analysts [4] - The Most Accurate Estimate for Ovid is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -1.45%, suggesting a bearish sentiment among analysts [10] Historical Performance - In the last reported quarter, Ovid was expected to post a loss of $0.16 per share but actually reported a loss of $0.13, achieving a surprise of +18.75% [12] - Over the past four quarters, Ovid has beaten consensus EPS estimates three times [13] Comparative Industry Analysis - ImmunityBio (IBRX), another player in the Zacks Medical - Biomedical and Genetics industry, is expected to report earnings per share of $0.12 for the same quarter, indicating a year-over-year change of +40% [17] - ImmunityBio's revenues are projected to be $15.69 million, up 39125% from the previous year [17] - The consensus EPS estimate for ImmunityBio has been revised 1.5% lower over the last 30 days, resulting in an Earnings ESP of -2.85% [18]